B.Riley initiates Nutex Health coverage with Buy rating, $290 target

Key Facts

1B.Riley initiated coverage on Nutex Health Inc. with a Buy rating and a $290 price target.

Reflecting confidence in alternative healthcare models, B.Riley initiated coverage on Nutex Health Inc. with a Buy rating and a price target of $290. According to the report, the rating is based on a positive assessment of the company's strategy in the micro-hospital space.

The analyst sees Nutex's micro-hospital model filling a clear gap in healthcare, particularly in underserved areas. The report highlights strong liquidity and a new sale-leaseback model supporting expansion, with expectations of 3 to 5 new hospital openings annually.

NUTX shares closed at $149.10 on June 25, 2026, well below the $290 target, leaving significant upside. Investors may watch for updates on expansion plans and upcoming quarterly results as potential catalysts.